Literature DB >> 33389447

Deregulation of imprinted genes expression and epigenetic regulators in placental tissue from intrauterine growth restriction.

Carla Caniçais1,2, Sara Vasconcelos1,2, Carla Ramalho2,3, C Joana Marques4,5, Sofia Dória6,7.   

Abstract

PURPOSE: Intrauterine growth restriction (IUGR) is a fetal growth complication that can be caused by ineffective nutrient transfer from the mother to the fetus via the placenta. Abnormal placental development and function have been correlated with abnormal expression of imprinted genes, which are regulated by epigenetic modifications at imprinting control regions (ICRs). In this study, we analyzed the expression of imprinted genes known to be involved in fetal growth and epigenetic regulators involved in DNA methylation, as well as DNA methylation at the KvDMR1 imprinting control region and global levels of DNA hydroxymethylation, in IUGR cases.
METHODS: Expression levels of imprinted genes and epigenetic regulators were analyzed in term placental samples from 21 IUGR cases and 9 non-IUGR (control) samples, by RT-qPCR. Additionally, KvDMR1 methylation was analyzed by bisulfite sequencing and combined bisulfite restriction analysis (COBRA) techniques. Moreover, global DNA methylation and hydroxymethylation levels were also measured.
RESULTS: We observed increased expression of PHLDA2, CDKN1C, and PEG10 imprinted genes and of DNMT1, DNMT3A, DNMT3B, and TET3 epigenetic regulators in IUGR placentas. No differences in methylation levels at the KvDMR1 were observed between the IUGR and control groups; similarly, no differences in global DNA methylation and hydromethylation were detected.
CONCLUSION: Our study shows that deregulation of epigenetic mechanisms, namely increased expression of imprinted genes and epigenetic regulators, might be associated with IUGR etiology. Therefore, this study adds knowledge to the molecular mechanisms underlying IUGR, which may contribute to novel prediction tools and future therapeutic options for the management of IUGR pregnancies.

Entities:  

Keywords:  DNA hydroxymethylation; DNA methylation; Genomic imprinting; Intrauterine growth restriction; Placenta

Mesh:

Substances:

Year:  2021        PMID: 33389447      PMCID: PMC8079450          DOI: 10.1007/s10815-020-02047-3

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  54 in total

Review 1.  Genomic imprinting: parental influence on the genome.

Authors:  W Reik; J Walter
Journal:  Nat Rev Genet       Date:  2001-01       Impact factor: 53.242

Review 2.  Genomic imprinting in mammalian development: a parental tug-of-war.

Authors:  T Moore; D Haig
Journal:  Trends Genet       Date:  1991-02       Impact factor: 11.639

Review 3.  Growth and function of the normal human placenta.

Authors:  Neil M Gude; Claire T Roberts; Bill Kalionis; Roger G King
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

4.  Decreased placental methylation at the H19/IGF2 imprinting control region is associated with normotensive intrauterine growth restriction but not preeclampsia.

Authors:  D K Bourque; L Avila; M Peñaherrera; P von Dadelszen; W P Robinson
Journal:  Placenta       Date:  2010-01-08       Impact factor: 3.481

Review 5.  Unearthing the roles of imprinted genes in the placenta.

Authors:  F F Bressan; T H C De Bem; F Perecin; F L Lopes; C E Ambrosio; F V Meirelles; M A Miglino
Journal:  Placenta       Date:  2009-08-12       Impact factor: 3.481

Review 6.  The effects of Assisted Reproductive Technologies on genomic imprinting in the placenta.

Authors:  Eric A Rhon-Calderon; Lisa A Vrooman; Laren Riesche; Marisa S Bartolomei
Journal:  Placenta       Date:  2019-03-04       Impact factor: 3.481

Review 7.  Genomic imprinting, growth and maternal-fetal interactions.

Authors:  Féaron C Cassidy; Marika Charalambous
Journal:  J Exp Biol       Date:  2018-03-07       Impact factor: 3.312

Review 8.  Genomic imprinting in the human placenta.

Authors:  David Monk
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

Review 9.  TET enzymes and DNA hydroxymethylation in neural development and function - how critical are they?

Authors:  Mafalda Santiago; Claudia Antunes; Marta Guedes; Nuno Sousa; C Joana Marques
Journal:  Genomics       Date:  2014-09-06       Impact factor: 5.736

10.  Parent-of-origin-specific allelic expression in the human placenta is limited to established imprinted loci and it is stably maintained across pregnancy.

Authors:  Diana Pilvar; Mario Reiman; Arno Pilvar; Maris Laan
Journal:  Clin Epigenetics       Date:  2019-06-26       Impact factor: 6.551

View more
  5 in total

Review 1.  Epigenetic processes during preeclampsia and effects on fetal development and chronic health.

Authors:  Usman M Ashraf; Dalton L Hall; Adam Z Rawls; Barbara T Alexander
Journal:  Clin Sci (Lond)       Date:  2021-10-15       Impact factor: 6.124

2.  Maternal neuropeptide galanin levels in pregnancies with intra-uterine growth restriction (IUGR): neurohormonal regulation of fetal weight.

Authors:  Berna Şermin Kılıç; Nil Atakul; Şahabettin Selek; Yıldız Atamer
Journal:  Ir J Med Sci       Date:  2022-08-22       Impact factor: 2.089

Review 3.  Epigenetics Beyond Fetal Growth Restriction: A Comprehensive Overview.

Authors:  Noemi Salmeri; Ilma Floriana Carbone; Paolo Ivo Cavoretto; Antonio Farina; Danila Morano
Journal:  Mol Diagn Ther       Date:  2022-08-26       Impact factor: 4.476

4.  [Correlation of Lipin gene expression with hepatic fat content in rats with intrauterine growth retardation].

Authors:  Jing Bian; Ping-Yang Chen; Du-Jun Bian; Xiao-Ri He; Alpha Kalonda Mutamba; Tao Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-04-15

5.  Placental endocrine insufficiency programs anxiety, deficits in cognition and atypical social behaviour in offspring.

Authors:  David J Harrison; Hugo D J Creeth; Hannah R Tyson; Raquel Boque-Sastre; Susan Hunter; Dominic M Dwyer; Anthony R Isles; Rosalind M John
Journal:  Hum Mol Genet       Date:  2021-09-15       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.